COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
11/02/2026
CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the expansion of its digital [...]
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices
11/02/2026
Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices Paris, France (11 février 2026 – 18h00) – Réuni aujourd’hui, le Conseil d’administration d’ [...]
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
11/02/2026
EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors Paris, France (11 February 2026 – 6:00pm) – During its meeting today, EssilorLuxottica Board of Directors decided to propose to the Shareholders’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026
11/02/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares – January 2026
11/02/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
11/02/2026
The Company is in Advanced Stage s of Commercial U.S. Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review ; Submission Expected to Begin by the E nd of the First Quarter of [...]
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
11/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today [...]
MBX Biosciences to Participate in Upcoming Investor Conferences
11/02/2026
CARMEL, Ind., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel precision peptide [...]
iMDx Announces $26.0 Million Registered Direct Offering
11/02/2026
NASHVILLE, Tenn., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (“iMDx” or the “Company”), today announced that it has entered into definitive agreements with certain [...]
Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
11/02/2026
Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National Launch Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non- [...]
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
11/02/2026
REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced [...]
Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis
11/02/2026
SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced a partnership with Orygen to initiate a Phase 2 [...]
Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026
11/02/2026
DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth [...]
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences
11/02/2026
LAGUNA HILLS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata Skin Sciences, Inc [...]
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders
11/02/2026
NORTH PALM BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to [...]
CorVent Medical Completes Common Stock Offering to Support Anticipated Launch of CorVision™ Remote Patient Monitoring (RPM) SaaS Platform
11/02/2026
Proceeds expected to fund company to profitability FARGO, N.D., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CorVent Medical, an innovative medtech company applying artificial intelligence (AI) and machine learning (ML) to improve [...]
Aveanna’s Heartways Program Receives CHAP Disease Program Certification
11/02/2026
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a [...]
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
11/02/2026
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide AGM182 Woodland, CA, Feb. 11, 2026 (GLOBE [...]
HNL Lab Medicine Opens New Patient Service Center at The Marketplace at Steamtown
11/02/2026
SCRANTON, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine is expanding access to convenient, high-quality laboratory services with the opening of a new Patient Service Center at The Marketplace at Steamtown, [...]

Pages